When assessing the financial health of a company, its EBITDA (earnings before interest, taxes, depreciation and amortization) is often the focus of buyers, especially those buying a company to grow by acquisition. In this episode Gower Idrees, CEO of RareBrain, explains why it is wiser to focus on free cash flow vs. EBITDA when acquiring a target company, and provides an example of how EBITDA can create a misperception of how much cash is actually available to service debt obligations.